Delivery of stromal-derived factor-1α via biocompatible gold nanoparticles promotes dendritic cells viability and migration

Combination of cancer immunotherapies and nanotechnology has shown to increase therapeutic efficiency and efficacy with less safety concerns. For an effective vaccine, activation and functional maturation of dendritic cells is a key step for the subsequent adaptive immune responses against cancer. Owing to superior biocompatibility, tunable physicochemical properties, low toxicity in immune cells and ease of functionalization by modifying...